Patients with fusiform basilar trunk aneurysms have a poor prognosis. Reconstructive endovascular therapy is possible with modern devices. We describe the clinical presentation, radiologic features, and clinical outcome of 13 patients with fusiform basilar trunk aneurysms treated with flow diverters, stents, and coils.
A neurysms of the basilar trunk are rare. They may be fusiform or saccular (sidewall). Fusiform aneurysms can be classified as segmental ectasia with a stretched and fragmented internal elastic lamina without intraluminal thrombus or as dissecting aneurysms with widespread disruption of the elastic lamina, thickened intima, and extensive intraluminal thrombus. Basilar trunk aneurysms most commonly present with SAH or mass effect due to brain stem compression and sometimes with ischemic stroke by dissection-induced occlusion of cerebellar or perforating arteries or by thromboembolism. When basilar trunk aneurysms are symptomatic, prognosis is poor. Ruptured dissecting basilar aneurysms are prone to rebleeding, with a high mortality. Basilar aneurysms that present with symptoms of mass effect on the brain stem and cranial nerves have a tendency to progressively increase in size with ultimately fatal mass effect. [1] [2] [3] [4] [5] Modern endovascular techniques allow reconstructive therapy for fusiform basilar trunk aneurysms. [6] [7] [8] [9] [10] [11] [12] [13] [14] We describe the clinical presentation, radiologic features, and clinical outcome of 13 patients with basilar trunk aneurysms who were treated with flow diverters, stents, and coils.
Materials and Methods

Patients
Between August 2005 and July 2011, thirteen patients with dissecting, fusiform, or dolichoectatic basilar trunk aneurysms were treated with reconstructive endovascular techniques by using coils, stents, and flow diverters. Patient and treatment characteristics are summarized in the On-line Table. There were 7 men and 6 women, with a mean age of 59.7 years (median, 61 years; range, 33-70 years). Clinical presentation was SAH in 3 patients, mass effect on the brain stem in 4 patients, posterior inferior cerebellar artery infarction following distal vertebral dissection in 1 patient; and in 5 patients, the aneurysm was an incidental finding on imaging studies for unrelated symptoms. Mean aneurysm size on cross-sectional imaging was 21 mm (median, 20 mm; range, 9 -30 mm). Of 13 aneurysms, 11 were large or giant and 9 were partially thrombosed.
Endovascular Treatment
Indications for treatment of patients with symptomatic and incidental basilar trunk aneurysms were discussed in a joint meeting with neurologists, neurosurgeons, and neuroradiologists. Treatment was tailored to the individual patient, accounting for various clinical and imaging parameters such as clinical presentation, patient age, the results of (serial) imaging, the presence of comorbidity, and patient preference. The choice of technique and the use of devices (stents, flow diverters, and coils) were dependent on anatomic geometry, size and length of the aneurysmal lumen, and the availability of devices. In the beginning of the study period, flow diverters were not yet available in our hospital. We preferred placing coils in the aneurysmal lumen after stent placement; when 2 good-caliber vertebral arteries were present, we preferred distal occlusion of 1 to decrease the flow into the aneurysm.
Endovascular treatment was performed with the patient under general anesthesia and with systemic heparinization on a biplane angiographic unit (Allura Neuro; Philips Healthcare, Best, the Netherlands) equipped with 3DRA.
Patients were preloaded with clopidogrel and aspirin. Angiography and 3DRA were performed through a single or bilateral vertebral artery contrast injection. Stable access to the basilar artery for stent placement was established with a 90-cm 6F introducer sheath (Destination; Terumo, Leuven, Belgium) positioned in the subclavian artery followed by insertion of a flexible 6F introducer catheter (Fargo; Balt, Montmorency, France) high in the vertebral artery, preferably in the V3 segment. In patients with 2 accessible vertebral arteries, a 5F introducer catheter was placed in the contralateral artery for control angiography and guidance of a second microcatheter if needed. From 3DRA images, the length and diameter of the stent were calculated by using standard machine software. For small stent sizes up to 4.5-mm vessel diameter and 32-mm length, an Enterprise stent was used (Codman, Raynham, Massachusetts), and for larger stent sizes, a LEO stent was used (Balt). Stents were telescopically placed in patients where long arterial segments needed to be bridged. In 2 patients, LEO stents were used as scaffolds to prevent shortening of telescopically placed Silk flow diverters (Balt). After stent placement, additional coils (Axium; ev3, Irvine, California) were inserted in the aneurysmal lumen in 12 of the 13 aneurysms, either via a microcatheter through the stent struts or via a previously jailed microcatheter. To further decrease the flow in the aneurysm in an attempt to promote luminal thrombosis, in 4 of 13 patients, we finally occluded 1 of the 2 vertebral arteries with coils in the V4 segment just proximal to the vertebral junction.
After treatment, follow-up MR imaging or angiography was scheduled at 6 -12 weeks.
Results
The clinical and radiologic results are summarized in the Online Table. In all 13 patients, it was technically feasible to place the stents, flow diverters, and coils as intended.
Complications of treatment occurred in 4 patients. Patient 3 (Fig 1) had a hemiparesis immediately after treatment and a brain stem infarction on MR imaging. Patient 4 experienced a myocardial infarction during general anesthesia, resulting in cardiac decompensation for which hospitalization of 4 weeks was necessary. Patient 7 did not wake up from general anesthesia, and repeat angiography demonstrated complete basilar thrombosis. Mechanical thrombectomy was successful, but the patient was brain dead and died the next day. Patient 10, who had a concomitant disseminated bile duct carcinoma, appeared mute following treatment. This condition remained until death from pulmonary embolism 3 weeks later.
Of 13 patients, 9 (69%) had a good functional outcome (GOS 1-2) at a median follow-up of 12 months (mean, 18; range, 6 -72 months). One patient (patient 2, 8%) who presented with SAH in poor clinical condition is dependent in a nursing home after 24 months. Three patients (23%) died shortly after treatment: Patient 3 died 4 weeks after treatment of a recurrent SAH despite adequate occlusion of the aneurysm with coils; patient 7 died directly after treatment from in-stent basilar thrombosis; and patient 10, who was mute since treatment, died 3 weeks later of a pulmonary embolism.
Of 3 surviving patients who presented with symptoms of mass effect on the brain stem, 2 improved neurologically and 1 was unchanged.
Representative Cases
Case 1, Patient 6. A 48-year-old man presented with intermittent dysphasia and dysarthria (Fig 1) . On MR imaging, a large and partially thrombosed basilar trunk aneurysm with brain stem compression was apparent. Angiography showed a giant fusiform dolichoectatic proximal basilar aneurysm. The aneurysm was treated with a Silk flow diverter telescopically placed in 2 overlapping LEO stents. The aneurysmal lumen was occluded with coils, and finally, the right vertebral artery was occluded with coils to decrease inflow in the basilar system. MR imaging follow-up at 3 months showed complete thrombosis of the aneurysm with unchanged aneurysm size. Clinically, there was no improvement of the brain stem symptoms.
Case 2, Patient 8. A 33-year-old man presented with a dissection of the right vertebral artery, resulting in a PICA infarction, an occlusion of the V4 segment of the right vertebral artery, and a large dissecting lower basilar aneurysm (Fig 2) . Because the distal part of the left vertebral artery was narrowed, apparently the dissection extended over the vertebral junction into the opposite left V4 segment. The dissecting basilar aneurysm was completely occluded with coils after stent placement over the aneurysm neck and the dissected and narrowed V4 segment of the left vertebral artery. Follow-up angiography at 14 months showed stable complete occlusion of the aneurysm. The patient made an uneventful clinical recovery.
Case 3, Patient 12.
A 65-year-old woman had a transient ischemic attack; on CT, a partially thrombosed fusiform basilar trunk aneurysm was found incidentally (Fig 3) . Angiography showed a large proximal fusiform basilar aneurysm in an ectatic vertebrobasilar system. The aneurysm was bridged with 3 telescopically placed LEO stents from the distal basilar artery into the distal right vertebral artery. Subsequently, the aneurysmal lumen was partially occluded with coils. Follow-up angiography at 6 months and 1 year showed progressive thrombosis of the aneurysm. Aneurysm size was unchanged at MR imaging. Clinically, she was asymptomatic.
Case 4, Patient 3.
A 70 -year-old woman presented with an SAH of Hunt and Hess grade III. CT angiography showed a giant aneurysm on the basilar artery (Fig 4) . Angiography confirmed the presence of a giant aneurysm on an ectatic and elongated basilar trunk, just distal to a proximal basilar fenestration. Three days later, a LEO stent was placed via the right vertebral artery in the basilar trunk across the aneurysmal neck. Subsequently, 1130 cm of coils was inserted in the aneurysmal lumen, and the aneurysm appeared adequately occluded. Several hours later, the patient developed a right-sided hemiplegia. MR imaging the next day showed a brain stem infarction and a small cerebellar infarction on the right side. The patient gradually neurologically improved and was discharged home 2 weeks later. Four weeks after treatment, she was found comatose at home, and a CT scan revealed a recurrent SAH. She died the next day.
Case 5, Patient 7. A 64-year-old man presented with abducens paresis. MR imaging showed a large dolichoectatic partially thrombosed proximal basilar aneurysm (Fig 5) . Angiography demonstrated the aneurysmal lumen and irregular and ectatic distal vertebral arteries. After telescopic placement of 2 LEO stents from the distal basilar artery into the right vertebral artery, a Silk flow diverter was inserted, the aneurysm lumen was filled with coils, and the left vertebral artery was occluded with a detachable balloon in the V4 segment. After embolization, the patient did not wake up from general anesthesia, and repeated right vertebral angiography showed in-stent thrombosis in the V4 segment. Mechanical thrombectomy was performed resulting in recanalization of the basilar artery, but with persistent occlusion of the right posterior cerebral artery. The clinical condition did not improve, and brain death was established. The patient died the same day.
Discussion
We found that with modern endovascular techniques and devices, reconstructive treatment of large and giant dolichoectatic and dissecting basilar trunk aneurysms is feasible. Conventional stents with sufficiently large diameters can be placed telescopically to negotiate long dilated and ectatic vessel segments and to serve as a scaffold for additional telescopically inserted flow diverters and/or coils in the remaining aneurysmal lumen.
Whether this kind of treatment improves the prognosis of patients with large fusiform basilar aneurysms remains an unanswered question. On the one hand, fusiform basilar artery aneurysms are associated with a high rate of mortality and disability. If left untreated, progressive brain stem compression or subarachnoid hemorrhage may occur with 2-year survival rates as low as 20%. [1] [2] [3] [4] [5] With SAH, the chance of rebleed is high and almost invariably fatal. 4, 5, 15, 16 In view of this poor natural history, treatment should be considered in symptomatic patients. Conventional surgical treatment consists of Hunterian arterial occlusion of the proximal basilar trunk or 1 or both vertebral arteries in patients with sufficient collateral circulation over the posterior communicating arteries. Other surgical methods consist of aneurysm wrapping, bleb clipping, or bypass surgery preceding vertebral or basilar occlusion. 1, 16, 17 In a report on 201 patients with predominantly giant posterior circulation aneurysms, treatment by surgical occlusion of the parent artery had good result in 68%, but 25% died. Outcome varied depending on the patient's condition on admission and the site of the aneurysm. 16 In recent years, surgical parent vessel occlusion has been largely replaced by endovascular techniques to occlude the vessels with detachable balloons or coils. With endovascular treatment, collateral circulation over the posterior communicating arteries can be tested in the awake patient before definitive occlusion. The few anecdotal reports and small case series on the treatment of giant vertebrobasilar aneurysms with balloon occlusion of afferent arteries vary widely with regard to patient selection and aneurysm characteristics. All authors agree to the importance of the size of the posterior communicating arteries to provide sufficient collateral flow to the territory of the occluded vessels. Little is known about the long-term treatment effect in respect to mass effect on the brain stem or prevention of primary or recurrent subarachnoid hemorrhage. 15, 18, 19 With the recent introduction of easy-to-place stents and flow diverters, reconstructive (instead of deconstructive) endovascular treatment is now possible in most patients with giant fusiform vertebrobasilar aneurysms. Although technically challenging, feasibility is high. Some technical issues are not yet clarified. Should the remaining aneurysm lumen after stent or flow diverter placement be filled with coils? Is an additional flow diverter placed in a conventional stent necessary or is a stent alone sufficient to induce thrombosis of the remaining part of the aneurysm? Is additional unilateral vertebral occlusion after stent placement necessary to decrease the flow and hence promote thrombosis of the aneurysm? If yes, should treatment be performed in a single session or staged? 20, 21 Our results in a limited series of 13 patients do not answer these questions. Of 13 patients, 9 had a good outcome with adequate aneurysm occlusion and stable aneurysm size on follow-up of 6 -72 months. One of 3 patients who presented with subarachnoid hemorrhage died of a rebleed despite angiographically adequate occlusion of the aneurysm. One other patient died soon after treatment of in-stent thrombosis, and another patient became mute after treatment. In 2 of 3 patients who presented with signs of mass effect, symptoms improved at a follow-up of 6 -24 months. Of 5 patients with incidentally discovered aneurysms, 4 had a good outcome after treatment and 1 patient with a disseminated carcinoma died eventually of pulmonary embolism. Our results are largely in concordance with the few scattered reports published so far on this type of treatment. Most patients do well, but serious complications are not uncommon. [6] [7] [8] [9] [10] [11] [12] [13] [14] 20, 21 In a recent report of 7 patients (6 symptomatic, 1 incidental) with fusiform vertebrobasilar artery aneurysms treated with flow diverters, 4 patients died, 1 was severely disabled, and only 2 did well. 14 Long-term effects or benefits of reconstructive endovascular treatment are not yet completely understood. So far, the complication rate of reconstructive treatment of fusiform vertebrobasilar artery aneurysms seems particularly high in symptomatic patients, while the outcome of treatment in patients with incidentally discovered aneurysms appears rather good. These findings would suggest that treatment should be offered in asymptomatic patients, especially when serial imaging indicates growth of the fusiform aneurysm. In patients presenting with (progressive) mass effect on the brain stem, treatment may be offered despite the risk of complications because the natural history is very poor. In patients presenting with subarachnoid hemorrhage, treatment is indicated in view of the high chance of recurrent hemorrhage.
Conclusions
Patients with large fusiform dolichoectatic and dissecting aneurysms of the basilar trunk are clinically challenging. The natural history is poor, especially when the aneurysm is symptomatic by mass effect or SAH. Therefore, reconstructive endovascular treatment may be offered in both symptomatic and asymptomatic patients, despite the substantial procedural risk and uncertain clinical benefit in the long term. More data are needed to elucidate the many clinical dilemmas involved in this patient group.
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